Personalized Medicine Toward Improved Patient Welfare and Profitable Drug Development

Drug development

Three patients Tito, Vice and Fidel present symptoms of rheumatoid arthritis. Doctors can prescribe drugs such as dexamethasone to alleviate the inflammation at a standard dosage. However, while Tito gets better from the treatment, Vic and Fidel return to the specialist for different reasons. Vic does not seem to benefit from the treatment and still present symptoms of arthritis whereas Fidel presents signs of adverse drug reactions. Should a drug in such cases be taken off the market or does it simply tell us that one dose does not fit all?

How these three patients respond to the same treatment can be attributed in part to how their bodies metabolize or break down the medicine. Recently, scientists have been looking into minor variations in genes that may determine how individuals process certain drugs to pave the way for personalized drug dosage based on whether a person is a fast, slow or normal metabolizer. For fast metabolizers, giving an insufficient dose may mean therapeutic failure. For slow metabolizers, giving a normal dose may mean accumulation of the drug in the system leading to an overdose.

The benefits of personalized medicine extend to drug development itself, which takes an average of 12 years and billions of dollars to bring to market, from an original pool of some ten thousand compounds screened. By identifying likely responders to a drug based on a person’s genetic variation, the efficacy of a candidate drug for a subset of patients can be gauged more easily, thus shortening drug development times and reducing costs. We do not wan potentially harmful compounds to be released to the public. An increased understanding of inter-individual variability in drug metabolism and a push towards personalized drug dosage and patient stratification will help ensure that investments in drug development will translate to profitable business as well as guarantee that safer compounds are made available to patients.

Genes Don’t Lie

At the Disease Molecular Biology and Epigenetics Laboratory, based at the National Institute of Molecular Biology and Biotechnology in the University of the Philippines Diliman, we work on research projects that will contribute to the advancement of personalized medicine. We try and find explanations as to why you and I process drugs differently and therefore require different dosages of any one drug. In particular, we study the effects of genetic variations called “microRNA binding site single nucleotide polymorphisms”, or MiRSNPs, in the regulation of drug metabolizing enzymes such as cytochrome 3A4(CYP3A4) and the pregnane X receptor.

Our laboratory attracts some of the best students in the institute and has won many awards locally and internationally since it was founded only 4.5 years ago. It is an excellent training ground for aspiring molecular and cellular biologists, which include both graduate and undergraduate thesis students as well as more junior apprentices. While we are not necessarily working on the same project, our troubleshooting skills, insights and perseverance all come into play. It is overwhelmingly satisfying to witness students actually enjoy the science of discovery, especially when it involves fundamentally important research such as personalizing drug dosage.

Through our research, we hope to contribute to the burgeoning field of personalized medicine. In the long-term, we want to focus on the Filipino population and add to the existing database of SNPs (single nucleotide polymorphism) to ensure that gene variations observed among Filipinos are taken into consideration when prescribing drugs and/or determining dosage. We envision a future wherein patients are stratified into likely responders or non-responders to a particular medication, drugs are prescribed according to one’s genetic variations and drug development made more efficient and cheaper because of advantages afforded by molecular biology.

Written by:
Reynaldo L. Garcia, Ph.D.
National Institute of Molecular Biology and Biotechnology
University of the Philippines Diliman

Published by:
Department of Science and Technology-Science and Technology Information Institute (DOST-STII)

Wonder Juana: A Selfless Volunteer

This 2021 National Women’s Month Celebration with the theme “Juana Laban sa Pandemya: Kaya!” is high time to emphasize the strong independent women and their extraordinary work. The pandemic continues to disrupt economies and social systems on a...

read more

Identifying the Dead through DNA Typing

Photo Credits: istockphoto While priority is usually food, clothing, housing and health care for survivors, emotional and psycho-social recovery is also important in the recovery process. This is why an important part of the rehabilitation process is to ensure the...

read more

Wonder Juana: A Selfless Volunteer

This 2021 National Women’s Month Celebration with the theme “Juana Laban sa Pandemya: Kaya!” is high time to emphasize the strong independent women and their extraordinary work. The pandemic continues to disrupt economies and social systems on a...

read more



We Are OneExpert

Hello. We are One Expert. And we are ready to serve you in many ways.

Whether you’re a startup person who needs training for your new business or someone looking to hone activities that promote technology transfer and commercialization, productivity enhancement and technical capability, skills upgrading, we have programs well suited to your needs and objectives.

Android Mobile App

The Department of Science and Technology (DOST) One Expert has stepped up its campaign with the creation of a mobile app to improve access to consultants and clients that need S&T assistance. The mobile application will drive an easier and better engagement of people to meet the delivery of DOST programs.


Birthday of National Scientist Ricardo M. Lantican

Dr. Lantican’s efforts in plant breeding have led off the release of notable varieties which are now commercially grown by farmers in the Philippines and many parts of Asia. The plant types evolved in the Philippines were used as parents in the breeding program of the...

read more

Enhancing MSME Productivity: MPEX Orientation

As part of the 2020 National Science and Technology (NSTW), DOST 6 conducts this webinar entitled ‘Enhancing MSME Productivity: MPEX Orientation’ with Engr. Baby R. Lim as resource speaker. MPEX or the Manufacturing Productivity Extension is one of the...

read more

DOST 6, PCAARRD, offer new rice & corn techs

Department of Science and Technology Regional Office VI (DOST VI) once again proved that even at the midst of a pandemic, the quality of service should not be affected by bringing the technological innovations in agriculture through a webinar called “Innovations...

read more

EXPERT-O turn up useful tech innovations

THE pandemic has demonstrated how science, technology, and innovation can significantly mitigate the debilitating impacts of CoVID-19.  DOST VI comes up with initiatives that answer the immediate concerns the society needs to fight the devastating scourge of the...

read more